The launch meeting of the safety evaluation research project for the tetravalent influenza virus subunit vaccine after its launch was a complete success

2023-11-06

Author: Internet

Recently, the launch meeting of the Ab&B Bio Tech CO., LTD. JS tetravalent influenza virus subunit vaccine post market safety evaluation research project was held in Lanzhou, Gansu. The post marketing safety evaluation research project of the tetravalent influenza virus subunit vaccine is a multicenter study led by the Jiangsu Provincial Center for Disease Prevention and Control, guided by the Jiangsu Provincial Center for Adverse Drug Reaction Monitoring, and jointly participated by the six provincial centers for disease prevention and control. The aim is to evaluate the safety of the tetravalent influenza virus subunit vaccine after vaccination in an expanded population of 3 years old and above, Improve the post market safety monitoring model of vaccines in China, establish a long-term active monitoring mechanism, and promote the vaccine regulatory system to move towards higher maturity goals.